Open Menu Close Menu

For projects that have the potential to advance the care of individuals living with BRCA1 and BRCA2 mutations. Research grant applications in basic science, prevention, early detection, or targeted therapeutics and relevant to the study of BRCA1/2 will be considered.
Grants that demonstrate a potential for translation into clinical practice will be prioritized for funding.